BIOENSIS’s Drug Combination Platform is designed to assist clients in navigating and functionally interpreting their data. Our robust methodologies facilitate the testing and analysis of interactions using powerful tools like Bliss and Isobologram analysis. This enhanced platform supports a wide range of testing conditions, with all experiments conducted under physiologically relevant conditions, and our cellular models accurately emulating in vivo activity.
BIOENSIS’ Drug Combinations assays:
• Flexible testing protocols for drug-drug combination
• Synergy, antagonism and additivity analysis
• Bliss and Isobologram analysis - are provided as well as IC50 and EC50 .
• Over 150 human tumor cell lines available for testing
• Available in 2D and 3D cultures
Please contact us to discuss your study and an up to date list of available cell lines
info@bioensis.com
